Heart rate turbulence and deceleration capacity for risk prediction of serious arrhythmic events in Marfan syndrome

Standard

Heart rate turbulence and deceleration capacity for risk prediction of serious arrhythmic events in Marfan syndrome. / Schaeffer, Benjamin N; Rybczynski, Meike; Sheikhzadeh, Sara; Akbulak, Ruken Ö; Moser, Julia; Jularic, Mario; Schreiber, Doreen; Daubmann, Anne; Willems, Stephan; von Kodolitsch, Yskert; Hoffmann, Boris A.

In: CLIN RES CARDIOL, 02.06.2015.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Schaeffer, B. N., Rybczynski, M., Sheikhzadeh, S., Akbulak, R. Ö., Moser, J., Jularic, M., Schreiber, D., Daubmann, A., Willems, S., von Kodolitsch, Y., & Hoffmann, B. A. (2015). Heart rate turbulence and deceleration capacity for risk prediction of serious arrhythmic events in Marfan syndrome. CLIN RES CARDIOL. https://doi.org/10.1007/s00392-015-0873-9

Vancouver

Bibtex

@article{249452f29d804213b852652669735cff,
title = "Heart rate turbulence and deceleration capacity for risk prediction of serious arrhythmic events in Marfan syndrome",
abstract = "OBJECTIVE: Marfan syndrome (MFS) is associated with a substantial risk for ventricular arrhythmia and sudden cardiac death (SCD). We used heart rate turbulence (HRT) and deceleration capacity (DC), to evaluate the risk stratification for these patients.METHODS: We enrolled 102 patients [45 male (44.1 %), age 40.5 ± 14.6 years] with MFS. Blood samples were obtained to determine N-terminal pro-brain natriuretic peptide (NT-proBNP) levels. Transthoracic echocardiography studies were conducted to evaluate heart function parameters and a 24-h holter ECG was performed. An analysis of two HRT parameters, turbulence onset (TO) and turbulence slope (TS), and DC was performed. Therefore, optimal cut-off values were calculated. Primary endpoint was the combination of SCD, ventricular arrhythmia and arrhythmogenic syncope. Secondary endpoint was total mortality.RESULTS: During a follow-up of 1145 ± 491 days, 12 (11.7 %) patients reached the primary and 8 (7.8 %) patients the secondary endpoint. Patients reaching the primary were significantly older, had a higher burden of premature ventricular complexes and NT-proBNP levels and lower values of LVEF, DC and HRT TS. Multivariate analysis identified NT-proBNP (HR 1.25, 95 % CI 1.01-1.56, p = .04) and the abnormal HRT (abnormal TS and/or TO (HR 7.04, 95 % CI 1.07-46.27, p = .04) as independent risk predictor of arrhythmogenic events.CONCLUSION: Patients with Marfan syndrome are at risk for severe ventricular arrhythmias and SCD. Abnormal HRT parameters and NT-proBNP values are independent risk factors for arrhythmogenic events and SCD. The assessment of these tools may help predicting SCD patients with MFS.",
author = "Schaeffer, {Benjamin N} and Meike Rybczynski and Sara Sheikhzadeh and Akbulak, {Ruken {\"O}} and Julia Moser and Mario Jularic and Doreen Schreiber and Anne Daubmann and Stephan Willems and {von Kodolitsch}, Yskert and Hoffmann, {Boris A}",
year = "2015",
month = jun,
day = "2",
doi = "10.1007/s00392-015-0873-9",
language = "English",
journal = "CLIN RES CARDIOL",
issn = "1861-0684",
publisher = "D. Steinkopff-Verlag",

}

RIS

TY - JOUR

T1 - Heart rate turbulence and deceleration capacity for risk prediction of serious arrhythmic events in Marfan syndrome

AU - Schaeffer, Benjamin N

AU - Rybczynski, Meike

AU - Sheikhzadeh, Sara

AU - Akbulak, Ruken Ö

AU - Moser, Julia

AU - Jularic, Mario

AU - Schreiber, Doreen

AU - Daubmann, Anne

AU - Willems, Stephan

AU - von Kodolitsch, Yskert

AU - Hoffmann, Boris A

PY - 2015/6/2

Y1 - 2015/6/2

N2 - OBJECTIVE: Marfan syndrome (MFS) is associated with a substantial risk for ventricular arrhythmia and sudden cardiac death (SCD). We used heart rate turbulence (HRT) and deceleration capacity (DC), to evaluate the risk stratification for these patients.METHODS: We enrolled 102 patients [45 male (44.1 %), age 40.5 ± 14.6 years] with MFS. Blood samples were obtained to determine N-terminal pro-brain natriuretic peptide (NT-proBNP) levels. Transthoracic echocardiography studies were conducted to evaluate heart function parameters and a 24-h holter ECG was performed. An analysis of two HRT parameters, turbulence onset (TO) and turbulence slope (TS), and DC was performed. Therefore, optimal cut-off values were calculated. Primary endpoint was the combination of SCD, ventricular arrhythmia and arrhythmogenic syncope. Secondary endpoint was total mortality.RESULTS: During a follow-up of 1145 ± 491 days, 12 (11.7 %) patients reached the primary and 8 (7.8 %) patients the secondary endpoint. Patients reaching the primary were significantly older, had a higher burden of premature ventricular complexes and NT-proBNP levels and lower values of LVEF, DC and HRT TS. Multivariate analysis identified NT-proBNP (HR 1.25, 95 % CI 1.01-1.56, p = .04) and the abnormal HRT (abnormal TS and/or TO (HR 7.04, 95 % CI 1.07-46.27, p = .04) as independent risk predictor of arrhythmogenic events.CONCLUSION: Patients with Marfan syndrome are at risk for severe ventricular arrhythmias and SCD. Abnormal HRT parameters and NT-proBNP values are independent risk factors for arrhythmogenic events and SCD. The assessment of these tools may help predicting SCD patients with MFS.

AB - OBJECTIVE: Marfan syndrome (MFS) is associated with a substantial risk for ventricular arrhythmia and sudden cardiac death (SCD). We used heart rate turbulence (HRT) and deceleration capacity (DC), to evaluate the risk stratification for these patients.METHODS: We enrolled 102 patients [45 male (44.1 %), age 40.5 ± 14.6 years] with MFS. Blood samples were obtained to determine N-terminal pro-brain natriuretic peptide (NT-proBNP) levels. Transthoracic echocardiography studies were conducted to evaluate heart function parameters and a 24-h holter ECG was performed. An analysis of two HRT parameters, turbulence onset (TO) and turbulence slope (TS), and DC was performed. Therefore, optimal cut-off values were calculated. Primary endpoint was the combination of SCD, ventricular arrhythmia and arrhythmogenic syncope. Secondary endpoint was total mortality.RESULTS: During a follow-up of 1145 ± 491 days, 12 (11.7 %) patients reached the primary and 8 (7.8 %) patients the secondary endpoint. Patients reaching the primary were significantly older, had a higher burden of premature ventricular complexes and NT-proBNP levels and lower values of LVEF, DC and HRT TS. Multivariate analysis identified NT-proBNP (HR 1.25, 95 % CI 1.01-1.56, p = .04) and the abnormal HRT (abnormal TS and/or TO (HR 7.04, 95 % CI 1.07-46.27, p = .04) as independent risk predictor of arrhythmogenic events.CONCLUSION: Patients with Marfan syndrome are at risk for severe ventricular arrhythmias and SCD. Abnormal HRT parameters and NT-proBNP values are independent risk factors for arrhythmogenic events and SCD. The assessment of these tools may help predicting SCD patients with MFS.

U2 - 10.1007/s00392-015-0873-9

DO - 10.1007/s00392-015-0873-9

M3 - SCORING: Journal article

C2 - 26033711

JO - CLIN RES CARDIOL

JF - CLIN RES CARDIOL

SN - 1861-0684

ER -